MARKET

NLSPW

NLSPW

Nls Pharmaceutic
NASDAQ
0.0108
0.0000
0.00%
Closed 15:16 03/21 EDT
OPEN
0.0108
PREV CLOSE
0.0108
HIGH
0.0108
LOW
0.0108
VOLUME
4.77K
TURNOVER
--
52 WEEK HIGH
0.0888
52 WEEK LOW
0.0051
MARKET CAP
--
P/E (TTM)
-0.0016
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NLSPW last week (0310-0314)?
Weekly Report · 5d ago
Weekly Report: what happened at NLSPW last week (0303-0307)?
Weekly Report · 03/10 12:27
Weekly Report: what happened at NLSPW last week (0224-0228)?
Weekly Report · 03/03 12:26
KADIMASTEM AND ITOLERANCE SUCCESSFULLY COMPLETE PRE-IND MEETING WITH THE FDA FOR ITS TYPE 1 DIABETES TREATMENT
Reuters · 02/25 14:05
Weekly Report: what happened at NLSPW last week (0217-0221)?
Weekly Report · 02/24 12:27
Weekly Report: what happened at NLSPW last week (0210-0214)?
Weekly Report · 02/17 12:23
NLS PHARMACEUTICS AND KADIMASTEM UNVEIL MULTI-TARGET APPROACH TO DIABETES, EXPANDING BEYOND GLP-1 THERAPIES
Reuters · 02/10 12:30
Weekly Report: what happened at NLSPW last week (0203-0207)?
Weekly Report · 02/10 12:13
More
About NLSPW
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.

Webull offers NLS Pharmaceutics AG stock information, including NASDAQ: NLSPW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NLSPW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NLSPW stock methods without spending real money on the virtual paper trading platform.